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to the energy expenditure of exercise (13). Because women with
EAMD frequently display disrupted profiles of leptin, triiodothyronine, insulin, and other peptides involved in energy homeostasis, their lower than expected RMRs are understood as evidence
of energy conservation (10, 12, 42).
However, because RMR varies considerably among individuals, it is difficult to quantify the full extent of RMR suppression
in response to chronic energy deficiency. Previous investigators
have addressed this issue by normalizing RMR for lean mass (10,
15, 21, 32) or by comparing measured RMR with predicted RMR,
which is derived from prediction equations that utilize anthropometric characteristics (10, 15, 21, 29, 38, 40). However, these
approaches may not be adequately sensitive to reflect the true
magnitude of RMR suppression (42). RMR is a product of the metabolic activity of various tissues, and metabolic rates vary considerably among these compartments (16). For example, the brain
and vital organs are characterized by high energy consumption,
whereas skeletal muscle, adipose tissue, and bone require considerably less energy at rest (16), and changes in the size or proportion of these compartments will result in characteristic differences in whole body RMR.
Therefore, a more in-depth analysis of RMR and the size of
metabolically active tissues is required to assess whether the apparent RMR suppression in chronically energy-deficient women
is simply a result of a reduced size of energetically expensive tissues or is in fact due to a reduction in metabolic rate at the tissue
level. The size of metabolically active tissues can be estimated using advanced imaging techniques such as whole body dual-energy
X-ray absorptiometry (DEXA), a technique widely used for body
composition and bone mineral density assessment (25). With this
knowledge, whole body RMR can be predicted using tissue-specific metabolic rates (18, 25, 46). Since this approach accounts for
differences in the size of metabolically active tissue compartments,
a reduced ratio of measured RMR to RMR predicted from the size
of metabolically active tissues could be a more sensitive indicator of energy conservation when compared with RMR predicted
from anthropometric characteristics or lean mass. To our knowledge, the comparison of measured and DEXA-predicted RMR has
been used only to document RMR suppression in anorexia nervosa patients (30). No investigator to date has used whole body
DEXA to examine the underlying mechanisms of RMR suppression in women with EAMD, a population that is of interest due to
1) the frequency of menstrual disturbances, which can be as high
as 60% among exercising women (20), and 2) the association of

Abstract
Exercising women with menstrual disturbances frequently display a low
resting metabolic rate (RMR) when RMR is expressed relative to body
size or lean mass. However, normalizing RMR for body size or lean mass
does not account for potential differences in the size of tissue compartments with varying metabolic activities. To explore whether the apparent RMR suppression in women with exercise-associated amenorrhea is
a consequence of a lower proportion of highly active metabolic tissue
compartments or the result of metabolic adaptations related to energy
conservation at the tissue level, RMR and metabolic tissue compartments
were compared among exercising women with amenorrhea (AMEN; n
= 42) and exercising women with eumenorrheic, ovulatory menstrual
cycles (OV; n = 37). RMR was measured using indirect calorimetry and
predicted from the size of metabolic tissue compartments as measured
by dual-energy X-ray absorptiometry (DEXA). Measured RMR was lower
than DEXA-predicted RMR in AMEN (1,215 ± 31 vs. 1,327 ± 18 kcal/day,
P < 0.001) but not in OV (1,284 ± 24 vs. 1,252 ± 17, P < 0.16), resulting in a lower ratio of measured to DEXA-predicted RMR in AMEN (91 ±
2%) vs. OV (103 ± 2%, P < 0.001). AMEN displayed proportionally more
residual mass (P < 0.001) and less adipose tissue (P = 0.003) compared
with OV. A lower ratio of measured to DXA-predicted RMR was associated with lower serum total triiodothyronine (ρ = 0.38, P < 0.001) and
leptin (ρ = 0.32, P = 0.004). Our findings suggest that RMR suppression
in this population is not the result of a reduced size of highly active metabolic tissue compartments but is due to metabolic and endocrine adaptations at the tissue level that are indicative of energy conservation.
Keywords: energy deficiency, metabolic adaptation, dual-energy
X-ray absorptiometry, lean body mass, exercise-associated menstrual
disturbances

Chronic energy deficiency results in a variety of metabolic adaptations that serve to conserve energy for essential processes
such as cellular maintenance, thermoregulation, and locomotion
(45). Energy-demanding processes not necessary for survival, including reproduction, may be surrendered in an environment of
energy deficiency (45). Among women of reproductive age, severe energy deficiency is associated with impaired reproductive
function, including functional hypothalamic amenorrhea (AMEN)
(39). As a result of these energy-conserving adaptations, resting
metabolic rate (RMR) is suppressed in chronically energy-deficient women, as observed in anorexia nervosa patients who exhibit
RMRs that are 20–40% lower than expected (29, 38, 40). Likewise,
lower than expected RMRs have also been reported in women with
exercise-associated menstrual disturbances (EAMD) (10, 15, 21),
a condition caused by insufficient dietary energy intake relative
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menstrual disturbances with poor skeletal, metabolic, and cardiovascular health (13).
The purpose of our study was to explore whether the lower
than expected RMR in women with EAMD is explained by a lower
proportion of tissues with high metabolic activity or whether it
is due to metabolic adaptations indicative of energy conservation. To this end, we sought to compare RMR, as measured by
indirect calorimetry, with RMR derived from whole body tissue
analysis in women at opposite ends of the EAMD spectrum in 1)
exercising women with functional hypothalamic AMEN and 2) a
control group of exercising women with ovulatory menstrual cycles (OV). We hypothesized that measured RMR would be significantly lower than DEXA-predicted RMR only in the AMEN group,
whereas measured and DEXA-predicted RMR would not be different in the OV group. We further hypothesized that when compared with ovulatory exercising women, AMEN women would not
demonstrate a lower proportion of energetically expensive tissues
such as brain, skeletal muscle, or residual mass but would demonstrate endocrine markers indicative of metabolic adaptations
and energy conservation such as reduced triiodothyronine and
leptin concentrations.
Methods
Study design. The current study is a cross-sectional analysis comparing exercising women with amenorrhea (AMEN) with exercising
women with ovulatory menstrual cycles (OV), who served as controls.
The study merges data from two data sets to include data from a
cross-sectional study on bone health among women of varying menstrual status (15) and the baseline period of a randomized controlled
trial designed to determine the effects of a dietary intervention of increased caloric intake on bone health and menstrual status in women
with EAMD (33, 35), with initial enrollments of n = 54 and n = 233,
respectively. Both studies were approved by the Institutional Review
Boards at the Pennsylvania State University and/or the University of
Toronto. Both studies were conducted by the same laboratory, and
procedures were standardized between protocols. The present analysis combines indirect calorimetry assessment of RMR and metabolic
tissue compartment sizes derived from DEXA. Participants completed
a monitoring period of 28 days (for AMEN women) or one menstrual
cycle (for OV women), during which menstrual status was confirmed.
All measurements occurred during or immediately before or after the
monitoring period, and participants were instructed to remain weight
stable and maintain their habitual exercise and dietary regimen during this time. The number and order of visits varied based on design
of the initial studies and the participants’ availability, but typically, all
measurements were completed within three to five visits.
Participants. Participants were recruited via fliers, classroom announcements, and newspaper and Internet advertisements. In the current analysis, participants were included if they met the following criteria: 1) age 18–35 yr, 2) body mass index between 18 and 30 kg/m2,
3) ≥2 h of purposeful moderate- to high-intensity exercise/wk, 4) nonsmoking, and 5) self-reported and laboratory evidence of AMEN or
regular ovulatory menstrual cycles, as described below. Women were
excluded if they had any health condition or were taking medications
that would affect metabolism or had a current clinical diagnosis of
an eating or psychiatric disorder. Women with elevated serum concentrations of prolactin, thyroid-stimulating hormone, and/or androgens were also excluded (1). To minimize the impact of menstrual cyclicity on RMR (2, 37, 47), we further excluded participants in whom
RMR data was not collected during the 1st wk (days 2–6) of the follicular phase.
Classification of menstrual status. Classification of menstrual status was based on self-reported menstrual history and confirmed by
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measurement of daily urinary reproductive hormone metabolites,
estrone-1-glucuronide (E1G), pregnanediol glucuronide (PdG), and
luteinizing hormone (LH) for one complete menstrual cycle in OV
or a 28-day monitoring period in AMEN. Urinary measurement of
E1G, PdG, and LH was conducted as published previously (14, 34). In
brief, in-house competitive immunoassays were used to determine
urinary E1G and PdG, and urinary LH was determined using an immunoradiometric assay (Siemens Healthcare Diagnostics, Deerfield,
IL). Concentrations of these urinary metabolites were corrected for
specific gravity to adjust for hydration. Amenorrhea was defined as
self-reported absence of menses for ≥90 days and was confirmed
by chronically suppressed concentrations of E1G and PdG during the
monitoring period (14). Women were considered ovulatory if they
reported at least nine menstrual periods in the past year and demonstrated a menstrual cycle length between 26 and 35 days, an E1G
peak concentration >35 ng/ml, an LH surge concentration >25 mIU/
ml that occurred on or after the day of the E1G peak, and a PdG peak
concentration >5 μg/ml during the luteal phase (14, 15). Ovulatory
women with luteal phase defects, as defined by a luteal phase <10
days in length (short luteal phase) or a peak luteal PdG concentration between 2.5 and 5 μg/ml (inadequate luteal phase), were included in the OV group (14). However, eumenorrheic women who
presented with an anovulatory cycle, as defined by peak luteal PdG
<2.5 μg/ml (14), were excluded.
Anthropometrics, health, and fitness. After participants gave informed consent, their height and body mass were measured and
their menstrual history, physical activity, and medical and psychological health assessed using lab-specific questionnaires, which asked for
past and current menstrual status, past physical activity and current
habitual exercise, overall health, injuries, use of medication, and previous diagnosis of a clinical eating disorder. To detect signs of an eating
disorder, participants completed the Eating Disorder Inventory-2 (19)
and subsequently met with a psychologist who completed a semistructured interview to exclude this diagnosis. During a separate visit, most
participants (81%) underwent a progressive treadmill test for peak oxygen uptake (V̇O2 peak). Following a brief warmup, participants started
running at a comfortable pace and a 0% incline. The incline was increased gradually by 2% every 2 min for the first 6 min and then by
1% every minute thereafter until volitional exhaustion was reached.
Throughout the test, oxygen uptake was measured using an on-line
MedGraphics (St. Paul, MN) Modular V̇O2 System or Sensor- Medics
(Yorba Linda, CA) Vmax metabolic cart, as described previously (42).
Resting metabolic rate. RMR was assessed via indirect calorimetry
using a ventilated hood (Vmax ; CareFusion, Yorba Linda, CA), as described elsewhere (8). In short, testing occurred between 0600 and
1000 following an overnight fast and abstention from alcohol, caffeine, and exercise for ≥24 h. After subjects rested in a supine position for 30–45 min, a ventilated hood was placed over their head, and
respiratory gas exchange was measured for ≥30 min. RMR was calculated from steady-state oxygen uptake and carbon dioxide production (49). RMR measurements were conducted either during or immediately following the menstrual status monitoring period. To minimize
the impact of menstrual cyclicity on RMR (2, 37, 47), only RMR data
collected during the early follicular phase, defined as the 1st wk after
the onset of menses, were included in the analysis.
Whole body dual energy X-ray absorptiometry. Whole body DEXA
scans were performed by a certified technician. In the majority of participants (71%), DEXA measurements were conducted prior to the start
of the monitoring period. In the remaining participants (29%), we included DEXA data that were collected within 1 wk of the RMR. Participants were scanned on a GE Lunar (Madison, WI) Prodigy DEXA scanner (enCORE 2002 software, version 6.50.069) (n = 49), a GE Lunar
iDEXA scanner (n = 24) (enCORE 2008 software version 12.10.113), or
a Hologic QDR4500W DEXA scanner (n = 6) (Hologic, Bedford, MA).
Cross-calibration studies consistent with the guidelines of the International Society of Clinical Densitometry were performed to remove
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system bias. For cross-calibration between the Lunar Prodigy and
iDEXA, 14 women were scanned in triplicate on both devices within 1
mo. All measurements included in the present analysis were highly correlated among both devices (r > 0.87). For cross-calibration between
the Hologic QDR4500W and Lunar iDXA, 32 women were scanned in
duplicate on both devices on the same day. High correlations among
both devices were observed for all measurements included in the present analysis (r > 0.93). To remove system bias, values obtained from
the Lunar Prodigy and Hologic QDR- 4500W were calibrated to the
Lunar iDEXA.
Modeling of organ tissue mass. Following whole body DEXA analysis, the organ tissue mass of the brain, skeletal muscle, bone, adipose
tissue, and residual tissue were determined as follows (25):
Brain mass = 0.005 × skull area (in cm2) + 0.2 × sex* + 0.24,
Skeletal muscle mass = 1.13 × lean tissue in extremities (kg)
– 0.02 × age (yr) + 0.61 × sex + 0.97
Bone mass = 1.85 × bone mineral content (kg)
Adipose tissue mass = 1.18_ fat mass (kg)
where sex (*) = 0 for female and sex = 1 for male.
Residual mass was defined as the difference between total body
mass and the sum of brain, skeletal muscle, bone, and adipose tissue mass (25).
Skull area was defined as head area (cm2) obtained from whole
body ancillary results and referred to the area superior to the bottom
of the mandible. Lean mass (kg) in the extremities was obtained from
body composition results and referred to the area lateral to the glenohumeral joint (arms) and distal to the femoral neck (legs). Bone mineral content and fat mass were obtained from whole body analyses.
Prediction of resting metabolic rate from organ tissue mass. Using previously published tissue coefficients of 240 kcal·kg–1·day–1 for
brain, 13 kcal·kg–1·day–1 for skeletal muscle, 4.5 kcal·kg–1·day–1 for adipose tissue, 2.3 kcal·kg–1·day–1 for bone, and 43 kcal·kg–1·day–1 for residual mass (16, 25), tissue-specific metabolic rates were calculated
as the product of the organ tissue mass and the respective tissue coefficients. DEXA-predicted RMR was calculated as the sum of the tissue-specific metabolic rates of brain, skeletal muscle, adipose tissue,
bone, and residual mass.
Metabolic hormones. Following an overnight fast of ≥12 h and abstention from exercise and caffeine for 24 h, blood samples were collected between 0700 and 1000 on one to two occasions during or
immediately following the menstrual status monitoring period. As described previously (8), samples were pooled prior to analysis, and serum concentrations of total triiodothyronine (TT3) were analyzed using a chemiluminescence immunoassay analyzer (Immulite; Diagnostic
Products, Los Angeles, CA) with a sensitivity of 35 ng/dl and intra- and
interassay coefficients of variation of 13.2 and 15.6%, respectively. Serum leptin was measured using an ELISA (Millipore, St. Charles, MI)
with a sensitivity of 0.5 ng/ml and inter- and intra-assay coefficients
of variations of 6.2 and 4.6%, respectively. All samples were measured
in duplicate.
Statistical analyses. Statistical analyses were performed with R (version 2.14.1). If not stated otherwise, data were reported as means ± SE.
Normality was assessed using the Shapiro-Wilk test. For normally distributed variables, group differences between the AMEN group and the
OV group and difference among measured and predicted RMR within
groups were assessed using one-way analysis of variance. For not normally distributed data, the Kruskal-Wallis test was used to identify differences. Spearman’s correlation coefficient (ρ) was assessed to determine
associations between RMR and serum TT3 and leptin concentrations.
The level of significance (α) was set at P < 0.05.

Results
Participants. Among the 287 women who were initially enrolled in the two original studies, 208 were excluded because of
incomplete data or because they did not meet the criteria for
inclusion in this study or our criteria for menstrual status classification (Fig. 1). Among the remaining 79 women, 42 qualified
as AMEN and 37 qualified as OV. AMEN women were slightly
younger (P = 0.010) and taller (P = 0.005) and exhibited a lower
body mass index (P = 0.028) and body fat percentage (P = 0.024)
when compared with OV women (Table 1). There were no significant differences between the AMEN group and the OV group
with respect to body mass, fat mass, lean mass, aerobic fitness,
and self-reported weekly exercise. The primary type of exercise
involved aerobic exercise (running, cycling, cardio training, swimming, triathlon, or aerobics) for the majority of the women (72%).
The remaining women conducted resistance exercise (4%) or exercise involving both aerobic and resistance components (24%),
such as soccer, dance, tennis, pentathlon, field hockey, lacrosse,
or both aerobic and strength training. Primary type of exercise
was not different between the AMEN group and the OV group
(χ2 = 1.22, P = 0.58).
Menstrual characteristics. Menarche occurred at a slightly older
age in the AMEN group compared with the OV group (13.1 ± 0.2
vs. 12.2 ± 0.2, P = 0.002). At the time of the study, AMEN women
had been amenorrheic for 292 ± 39 days (range: 90–1,642 days).
In the OV group, the average menstrual cycle length was 29.6 ±
0.4 days, with follicular and luteal phases of 18.9 ± 0.5 and 10.7
± 0.3 days, respectively. Five women in the OV group (13%) demonstrated luteal phase defects, which were attributed to short luteal phases (n = 3) or a combination of short and inadequate luteal phases (n = 2). The AMEN group demonstrated chronically
suppressed concentrations of urinary E1G and PdG throughout
the 28-day monitoring period, whereas the OV group exhibited
characteristic late-follicular and luteal rises in E1G and PdG, respectively (Fig. 2). When compared with the OV group, the AMEN
group demonstrated lower mean concentrations of E1G (25.0 ±
1.7 vs. 46.2 ± 3.4 ng/ml, P < 0.001) and PdG (1.0 ± 0.1 vs. 2.5 ± 0.2
μg/ml, P < 0.001) as well as lower areas under the curve for E1G
(678 ± 48 vs. 1,316 ± 95 ng·day–1·ml–1, P < 0.001) and PdG (26.3 ±
2.3 vs. 72.6 ± 4.7 μg·day–1·ml–1).
Comparison of measured and predicted resting metabolic rate.
Measured RMR was not significantly lower in the AMEN group
when compared with the OV group when expressed in absolute
numbers (P = 0.08) but was lower when expressed relative to lean
mass (P < 0.001; Table 2). In contrast, DEXA-predicted RMR was
significantly higher in the AMEN group when compared with the
OV group (P = 0.004). Consequently, in the AMEN group, measured RMR was, on average, 112 ± 26 kcal/day lower than DEXApredicted RMR (P < 0.001; Table 2), whereas measured and DEXApredicted RMR were similar in the OV group (P = 0.16). The ratio of
measured to DEXA-predicted RMR (Fig. 3) was significantly lower
in the AMEN group (92 ± 2%) when compared with the OV group
(103 ± 2%, P < 0.001).
Size of metabolically active tissue compartments. On average,
the AMEN group exhibited 1.6 kg less adipose tissue (P = 0.008)
and 1.7 kg more residual mass (P < 0.001) when compared with
OV group (Table 3). The differences between the AMEN group
and the OV group with regard to adipose tissue (P = 0.005) and
residual mass (P < 0.001) remained significant even after the size
of metabolic tissue compartments for body mass was normalized.
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Fig. 1. Inclusion and exclusion of
participants. *See Ref. 33. **See Ref. 15.
***Exercising women with amenorrhea
(AMEN) were defined by self-reported
absence of menses for ≥90 days and
chronically suppressed urinary estrone1-glucuronide (E1G) and pregnanediol
glucuronide (PdG) throughout the
monitoring period (14); exercising women
with ovulatory cycles (OV) were defined by
≥9 self-reported menses in the past year, a
monitored menstrual cycle length between
26 and 35 days, an E1G peak concentration
>35 ng/ll, an LH surge concentration >25
mIU/ml occurring on or after the day of
the E1G peak, and a PdG concentration
>2.5 μg/ml during the luteal phase (14, 15).
DEXA, dual-energy X-ray absorptiometry;
RMR, resting metabolic rate; BMI, body
mass index.

There were no significant differences in the absolute and relative
sizes of brain, skeletal muscle, or bone mass between the AMEN
group and the OV group.
Table 1. Anthropometric and exercise characteristics of the study
participants
Characteristic

AMEN (n = 42)

Age, yr
22.3 ± 0.5
Height, cm
168 ± 1
Body mass, kg
58.4 ± 1.0
Body mass index, kg/m2
20.8 ± 0.3
Fat mass, kg
12.7 ± 0.7
Body fat, %
21.5 ± 0.9
Lean body mass, kg
43.1 ± 0.8
Lean mass index, kg/m2
15.3 ± 0.2
V ˙ O2peak, ml·kg–1·min–1†
49.3 ± 1.6
Self-reported exercise, min/wk 450 ± 44

OV (n = 37)
24.7 ± 0.7*
164 ± 1**
58.2 ± 0.8
21.6 ± 0.2*
13.9 ± 0.5
24.1 ± 0.8*
41.1 ± 0.6
15.2 ± 0.2
47.1 ± 1.3
396 ± 34

Values are means ± SE. AMEN, women with exercise-associated amenorrhea; OV, exercising women with ovulatory menstrual cycles; V̇ O2peak ,
peak oxygen uptake. *P < 0.05 vs. AMEN; **P < 0.01 vs. AMEN; †sample
size for V̇ O2peak : n = 32 AMEN and = 32 OV.

Association of metabolic and reproductive hormones with resting metabolic rate. When compared with the OV group, the AMEN
group demonstrated lower serum concentrations of TT3 (80.6 ±
3.3 vs. 90.6 ± 2.2 ng/dl, P = 0.012) and leptin (5.1 ± 0.9 vs. 7.9 ±
0.8 ng/ml, P < 0.001). The difference in leptin among the AMEN
group and the OV group remained significant even when serum
leptin was adjusted for the size of adipose tissue (0.28 ± 0.04
ng·ml–1·kg–1 vs. 0.42 ± 0.04, P _ 0.001). The ratio of measured to
DEXA-predicted RMR was significantly correlated to serum TT3 (ρ
= 0.38, P < 0.001; Fig. 4) and leptin (ρ = 0.32, P = 0.004; Fig. 4).
There was no significant correlation between the ratio of measured
to DEXA-predicted RMR and mean concentrations as well as areas
under the curve for E1G and PdG (all P > 0.14).
Discussion
The primary finding of this cross-sectional study was that, after
accounting for differences in the size of the main metabolic tissue
compartments, measured RMR in exercising women with amenorrhea was on average 8% lower than predicted, whereas there was
no difference between measured and predicted RMR in exercising women with ovulatory menstrual cycles. Consistent with the
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Fig. 3. Comparison of the ratio of measured to DEXA-predicted RMR
among women with exercise-associated amenorrhea (AMEN) and exercising women with ovulatory menstrual cycles (OV). Bold horizontal
lines denote the median. Bottom and top of the boxes indicate the 1st
and 3rd quartile, respectively, and dashed lines denote the interquartile range. ***P < 0.001.

Fig. 2. Composite graphs of urinary estrone-1-glucuronide (E1G; ●) and
pregnanediol glucuronide (PdG; ○) across the 28-day monitoring period in exercising women with amenorrhea (AMEN; top) and across 1
menstrual cycle in exercising women with ovulatory cycles (OV; bottom).

lower than predicted RMR, exercising women with amenorrhea
also demonstrated reduced serum concentrations of TT3 and
leptin compared with exercising women with ovulatory cycles.
Furthermore, the size of tissue compartments with high metabolic activity (brain, skeletal muscle, and residual mass) was not
reduced in exercising women with amenorrhea, suggesting that
low RMR in this population is not explained by an altered tissue
composition. Rather, the suppressed RMR in exercising women
with amenorrhea may be attributed to alterations in the metabolic activity of tissues. Taken together, these findings are important because they suggest that women with exercise-associated
amenorrhea suffer from metabolic suppression as an adaptive
response to conserve energy.
Table 2. Measured and predicted RMR among AMEN and OV women
RMR

AMEN (n = 42)

Measured, kcal/day
Measured, kcal·kg

LBM–1·day–1

DEXA-predicted, kcal/day

1,215. ± 31
28.3 ± 0.6
1,327. ± 18###

OV (n = 37)
1,284. ± 24
31.3 ± 0.6***
1,252. ± 17**

Values are means ± SE. RMR, resting metabolic rate; AMEN, women
with exercise-associated amenorrhea; OV, exercising women with ovulatory menstrual cycles; LBM, lean body mass; DEXA, dual-energy X-ray
absorptiometry. ###P < 0.001 vs. measured; **P < 0.01 vs. AMEN; ***P
< 0.001 vs. AMEN.

Our findings are in agreement with previous longitudinal experiments documenting that RMR decreases once an energy deficit is induced (23). Because this RMR reduction normally exceeds
the reduction in RMR expected from lean tissue losses, it is understood as an adaptive response to conserve energy (3, 4, 36,
41). Although a reduction in RMR is easily detectable in longitudinal settings, it is far more challenging to characterize RMR reductions cross-sectionally. Utilizing a novel approach that accounts
for differences in the size of metabolic tissue compartments as
determined by DEXA, we were able to demonstrate that RMR is
suppressed in chronically energy-deficient exercising women with
amenorrhea, whereas using the same approach we found that
measured and predicted RMR were in good agreement in our
control group of ovulatory exercising women. To our knowledge,
a similar approach has been utilized only in anorexia nervosa patients, in whom measured RMR was also lower than DEXA-predicted RMR (30). Because anorexia nervosa presents a model of
severe energy deficiency (39), it is not surprising that the 21% discrepancy between measured and DEXA-predicted RMR in these
patients was more pronounced compared with the 8% reduction
in our group of exercising women with amenorrhea, which did not
include women with clinical eating disorders. Furthermore, since
exercise has been shown to attenuate the reduction in RMR during calorie-restricted weight loss (44), their habitual exercise of
~7.5 h/wk may have protected our women from greater reductions in RMR.
The present study further expands upon previous reports of
low RMR in women with EAMD, in whom RMR is 14–20% lower
than predicted by the Harris-Benedict equation (10, 15, 21). However, the Harris-Benedict equation, which predicts RMR from
height, weight, and age (24), does not account for differences in
body tissue composition at all. To normalize RMR, some authors
have expressed RMR relative to the size of lean mass and reported
a 5–15% reduction in lean mass-adjusted RMR in women with
EAMD (10, 15, 21) and a 12–30% reduction in lean mass-adjusted
RMR in anorexia nervosa patients (32, 38, 40). However, this approach is also problematic because the contribution of lean mass
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Table 3. Absolute and relative size of the main metabolically active body compartments among AMEN and OV women
Compartment

Absolute Size, kg
AMEN (n = 42)

Brain mass

Relative Size, %total mass

OV (n = 37)

AMEN (n = 42)

OV (n = 37)

1.4 ± 0.0

1.4 ± 0.0

2.4 ± 0.0

2.4 ± 0.0

Skeletal muscle mass

21.8 ± 0.5

21.2 ± 0.4

37.6 ± 0.5

36.9 ± 0.5

Adipose mass

16.2 ± 0.7

17.8 ± 0.5**

27.5 ± 0.9

30.9 ± 0.7**

4.4 ± 0.1

4.5 ± 0.1

7.6 ± 0.1

7.8 ± 0.1

Bone mass
Residual mass

14.5 ± 0.3

12.8 ± 0.3***

25.1 ± 0.5

22.3 ± 0.4***

Values are means ± SE. AMEN, women with exercise-associated amenorrhea; OV, exercising women with ovulatory menstrual cycles; **P < 0.01 vs.
AMEN; ***P < 0.001 vs. AMEN.

to RMR is not constant (48). Although lean mass accounts for almost two-thirds of the variance in RMR in adults (27), it is composed of various tissues with highly variable metabolic rates (25).
Vital compartments such as the brain or inner organs require considerably more energy compared with nonvital compartments of
lean mass such as skeletal muscle (25). As a consequence, RMR,
when expressed in kcal/kg lean mass, is naturally higher in individuals with low lean mass and a high proportion of vital tissues
compared with individuals with high lean mass and a high proportion of nonvital tissues (48). As such, approaches that fail to
account for the contribution of these different metabolic tissue
compartments could lack the sensitivity to detect RMR suppression and characterize the full magnitude of metabolic adaptations.
In fact, we observed significant differences in the size of these
compartments among AMEN and OV after we divided lean mass
into its three major tissue compartments (skeletal muscle, brain,
and residual mass). When expressed relative to body size, the
AMEN group exhibited on average 13% more residual mass,
which is reflective of inner organ tissue such as heart, liver, and
kidney as well as other soft tissues (25). These vital tissue compartments are typically preserved during chronic energy deficiency (22) so that the greater proportion of residual mass in
AMEN is likely a result of the relative reduction in the size of
other tissue compartments. Because the degradation of tissue to
supply additional energy is limited mainly to easily expendable
compartments (22), it is not surprising that adipose tissue mass
was reduced in AMEN. However, the AMEN group did not demonstrate reduced skeletal muscle mass, another expendable tissue that can provide energy and, in particular, glucose to meet

energy requirements of the brain (5, 17). The apparent preservation of skeletal muscle mass in our group of AMEN is likely attributable to their exercise, which has the capacity to attenuate muscle loss during energy deficiency (44).
The association between metabolic adaptations indicative of
energy conservation and the induction and reversal of exerciseinduced amenorrhea secondary to changes in energy status has
been demonstrated in both animal and human models. When
female cynomolgus monkeys were exposed to an energy deficit
through increasing their exercise energy expenditure, they exhibited a 20% reduction in circulating TT3, which occurred concomitant with the onset of amenorrhea (50). Likewise, when dietary
energy was increased to compensate for the increased energy
expenditure of exercise, circulating TT3 returned to baseline levels, and the increase in TT3 coincided with the onset of menses
(50). Leptin is another key regulator of energy balance that is suppressed during energy deficiency induced by caloric restriction
and/or increased exercise (28, 31). The importance of leptin for reproductive function in women is highlighted by findings that the
suppression of leptin secondary to energy deficiency is concomitant with a suppression of LH pulsatility (31) and that administration of human recombinant leptin can revert the suppression of
the hypothalamic- pituitary-gonadal axis during energy deficiency
(6) and results in the recovery of menses in previously amenorrheic
women (7). Given the correlation between TT3, leptin, and the ratio of measured to DEXA-predicted RMR reported in the present
study, it is likely that changes in these metabolic hormones during
the transition between normal and suppressed reproductive function are paralleled by characteristic changes in RMR.
Fig. 4. Correlations between
the ratio of measured to
DEXA-predicted RMR and
serum concentrations of total
triiodothyronine (left) and leptin
(right) among women with
exercise-associated amenorrhea
(AMEN) and exercising women
with ovulatory menstrual cycles
(OV).
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Our results further inform our understanding of the energy
cost of human reproduction and, notably, that of normal menstrual function. The 8% reduction in RMR in women with completely absent menstrual cycles confirms that maintenance of
normal menstrual function is an energy-demanding process (26).
Because of this energy cost, it has been hypothesized that the
loss of menstrual function can act to conserve energy (26). However, to this day, the true energy cost of menstrual function remains largely unknown (26). Previously, estimations of energy requirements were based on metabolic rate fluctuations across the
menstrual cycle, which can be as high as 7–9% (2, 37, 47). These
transient changes in RMR across the menstrual cycle have been
attributed to an increase in progesterone during the luteal phase
(47). To date, the reduction in RMR caused by the complete suppression of menstrual function has been assessed in only one
study. Following ovarian suppression via administration of a gonadotropin-releasing hormone antagonist, RMR was reduced by
3–5% compared with RMR measured in the same women when
they were menstruating regularly (9). However, the pharmacological intervention lasted only 6 days and did not address longterm RMR changes following the loss of menstrual function. The
fact that the 8% RMR suppression in our sample exceeded the
short-term reduction in RMR following acute ovarian suppression, together with the lack of a significant association between
RMR suppression and urinary measurements of progesterone
and estrogen exposure, suggests that the suppression of RMR in
exercising women with amenorrhea is not caused exclusively by
reduced circulating ovarian steroids. Instead, these findings further support our hypothesis that RMR suppression in this group
is the result of metabolic adaptations in response to chronic energy deficiency.
Our findings and approach need to be confirmed in future
longitudinal trials in humans. A recent case study from our laboratory found that RMR increased in two recreational athletes
with EAMD who resumed menses while participating in a yearlong intervention of increased caloric intake (35). In both women,
the menstrual recovery coincided with an increase in RMR (35).
Since both women also demonstrated an increase in fat mass, it
is likely that these changes in RMR would have been even more
pronounced after accounting for changes in the size of metabolically active tissue compartments secondary to the intervention. Another limitation of the present study was that the use of
DEXA restricted us to assessing residual mass as a surrogate of
organ tissue mass as opposed to measuring the size of individual
organs. RMR prediction could be improved further by accounting for differences in the size of highly active metabolic organs
such as the liver, heart, or kidneys (16). In fact, others have utilized whole body magnetic resonance imaging (MRI) to assess
organ size and predict RMR (18, 46). However, in contrast to MRI,
DEXA is widely used in clinical and research settings and is associated with lower costs (25).
In summary, our results demonstrate that even after the prediction of whole body RMR is improved by accounting for differences
in the size of tissue compartments of varying metabolic rates, RMR
remained suppressed in exercising women with amenorrhea. These
findings suggest that RMR suppression in women with exerciseassociated amenorrhea is the result of a reduced metabolic activity at the tissue level, thus providing further evidence of energy
conservation in this population.
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